“Please note that this web site is not aimed at consumers as the information herein
contained does not make reference to finished products”.


Indena’s bioavailable curcumin formulation Meriva® at the XXIV International Congress on Sports RehabilitationMeriva_2015 and Traumatology.

Milan, April 7th, 2015 – Indena’s involvement in the growing sports nutrition market is confirmed by the company’s participation in the Football Medicine Strategies for Player Care Conference, to be held at The Queen Elizabeth II Conference Centre on April 11th and 12th.

For over two decades this conference has been the meeting point of the international Football Medicine Community, and will gather some 1600 sports medicine specialists and professionals from 77 different countries around the world.

On this occasion, Indena will present a study on Meriva®, its proprietary lecithin-based and diet inspired delivery system of curcumin, confirming that its specific curcumin formulation may aid in sports nutrition by attenuating Delayed Onset Muscle Soreness (DOMS) due to eccentric muscle activity[1].

The interest for Meriva® in sports nutrition has been further confirmed in a second recent study[2] published in 2015 by independent researchers from the Universities of Stirling and Malta, investigating the effect of a low dose of Meriva® supplementation on cytokine and inflammatory marker responses, following 2 hours of endurance cycling.  This study could provide the basis for future investigations with larger samples and multiple Meriva® dosages to determine if different curcumin regimens can lead to statistically different interleukin levels when compared to a control and placebo in endurance cycling.


[1] Drobnic F, Riera J, Appendino G, Togni S, Franceschi F, Valle X, Pons A, Tur J, Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial, Journal of the International Society of Sports Nutrition 2014, 11:31

[2] Sciberras et al., The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling, Journal of the International Society of Sports Nutrition (2015) 12:5.


*** ***


On Meriva®

Meriva® is a patented delivery form of curcumin utilizing Indena proprietary Phytosome® technology, for healthy inflammatory response and joint health. Pharmacokinetic comparison studies have shown Meriva® to improve bioavailability of curcuminoids by about 30-fold and significant absorption benefits. The product is supported by 16 clinical trials demonstrating effectiveness for joint health and inflammatory response support.

Further info on Meriva® and other Phytosome®s: www.phytosomes.info

Want to know more about Phytosome® technology? Watch the video Phytosome®:The technology explained on the Indena YouTube channel

Follow us on Twitter@IndenaSpA
Follow us on LinkedInhttps://www.linkedin.com/company/indena

Indena Press Contacts
Cohn & Wolfe Milan
Laura Faravelli        laura.faravelli@cohnwolfe.com
Lorenzo Petracco    lorenzo.petracco@cohnwolfe.com
Tel.+39 02 202391
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

Terms & Conditions | Privacy Notice | Cookie Policy | ©2018 Indena S.p.A. All right reserved Indena S.p.A. | tel. +3902574961 fax +390257404620 | P.IVA 04411780150